ALGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-05), Align Technology's share price is $169.88. Align Technology's Book Value per Share for the quarter that ended in Dec. 2024 was $52.16. Hence, Align Technology's PB Ratio of today is 3.26.
Good Sign:
Align Technology Inc stock PB Ratio (=3.26) is close to 10-year low of 3.26
The historical rank and industry rank for Align Technology's PB Ratio or its related term are showing as below:
During the past 13 years, Align Technology's highest PB Ratio was 25.78. The lowest was 3.26. And the median was 8.13.
During the past 12 months, Align Technology's average Book Value Per Share Growth Rate was 7.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 18.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 22.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Align Technology was 43.10% per year. The lowest was -12.20% per year. And the median was 16.70% per year.
The historical data trend for Align Technology's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
13.03 | 14.28 | 4.52 | 5.67 | 4.00 |
Align Technology Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
5.67 | 6.57 | 4.80 | 4.82 | 4.00 |
For the Medical Instruments & Supplies subindustry, Align Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's PB Ratio distribution charts can be found below:
* The bar in red indicates where Align Technology's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Align Technology's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Dec. 2024) |
= | 169.88 | / | 52.16 | |
= | 3.26 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Align Technology (NAS:ALGN) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Align Technology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Larkin C Raymond Jr | director | C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105 |
Joseph Lacob | director | 2820 ORCHARD PARKWAY, SAN JOSE CA 95131 |
Emory Wright | officer: VP, Operations | C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131 |
Joseph M Hogan | director, officer: President and CEO | C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281 |
Kevin J Dallas | director | C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134 |
John Morici | officer: Chief Financial Officer | C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131 |
Warren S Thaler | director | C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281 |
Anne Myong | director | 2820 ORCHARD PARKWAY, SAN JOSE CA 95141 |
Julie Ann Coletti | officer: SVP, Chief Legal & Regulatory | 2820 ORCHARD PARKWAY, SAN JOSE CA 95131 |
Greg J Santora | director | 4201 GRANT COURT, PLEASANTON CA 94566 |
Stuart A Hockridge | officer: VP, Global Human Resources | C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131 |
George J Morrow | director | AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
Andrea Lynn Saia | director | C/O COCA-COLA ENTERPRISES, INC., 2500 WINDY RIDGE PARKWAY, NW, 14TH FLOOR, ATLANTA GA 30339 |
Thomas M Prescott | director | C/O ALIGN TECHNOLOGY INC, 2820 ORCHARD PARKWAY, SAN JOSE CA 95131 |
Yuval Shaked | officer: SVP and Mgng Director, Itero | C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134 |
From GuruFocus
By GuruFocus News • 01-17-2025
By GuruFocus News • 12-06-2024
By Business Wire • 10-25-2024
By GuruFocus News • 01-02-2025
By GuruFocus News • 02-05-2025
By Business Wire • 02-05-2025
By Business Wire • 02-10-2025
By GuruFocus News • 01-16-2025
By Business Wire • 11-12-2024
By GuruFocus News • 10-24-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.